GE HealthCare Techs saw a positive improvement to its Relative Strength (RS) Rating on Friday, rising from 70 to 73.
IBD's proprietary RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the last 52 weeks matched up against all other stocks.
Decades of market research shows that the best-performing stocks tend to have an RS Rating of over 80 as they begin their largest climbs. See if GE HealthCare Techs can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
GE HealthCare Techs is building a flat base with a 94.55 buy point. See if the stock can clear the breakout price in heavy volume.
Taking a look at top and bottom line numbers, GE HealthCare Techs has posted rising EPS growth over the last five quarters. Revenue gains have also risen during the same period.
GE HealthCare Techs earns the No. 9 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, Brainsway ADR and Electromed are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
